Codexis Inc.

NASDAQ: CDXS · Real-Time Price · USD
2.39
0.05 (2.14%)
At close: May 22, 2025, 9:52 AM

Codexis Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Sitagliptin Enzyme Revenue 2.5M 27.24M 1.6M 3.05M 2.3M 57K 2.73M
Sitagliptin Enzyme Revenue Growth -90.82% +1602.31% -47.61% +32.61% +3940.35% -97.92% n/a
Research and Development Revenue Revenue 22.56M n/a 1.61M 2.8M n/a n/a n/a
Research and Development Revenue Revenue Growth n/a n/a -42.39% n/a n/a n/a n/a
Product Revenue 36.79M n/a n/a n/a n/a n/a n/a
Product Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 12.36M 13.05M 13.57M 15.45M 12.64M 10.97M 12.3M 13.37M 15.4M 12.31M 13.5M 10.66M 15.71M 11.72M 13.41M 12.79M 11.4M 8.74M 8.8M 8.52M 8.99M 7.32M 7.87M 7.9M 8.41M 6.81M 7.34M 7.39M 7.75M 7.87M 7.99M 6.55M 6.61M 6.97M 5.23M 6.42M 6.8M 6.03M 5.42M 5.3M 5.58M
Selling, General, and Administrative Revenue Growth -5.31% -3.83% -12.19% +22.25% +15.24% -10.84% -7.95% -13.21% +25.05% -8.78% +26.68% -32.15% +33.97% -12.56% +4.78% +12.26% +30.40% -0.64% +3.23% -5.20% +22.77% -6.95% -0.34% -6.17% +23.64% -7.33% -0.69% -4.53% -1.54% -1.53% +22.04% -0.91% -5.20% +33.26% -18.55% -5.62% +12.88% +11.28% +2.25% -5.06% n/a
Research and Development Revenue 1.48M 12.1M 11.51M 10.39M 10.21M 11.23M 13.66M 17.33M 16.66M 19.69M 21.82M 19.09M 19.5M 16.36M 15.16M 12.83M 11.57M 10.36M 12.01M 10.85M 10.97M 8.87M 8.71M 8.27M 8.02M 7.51M 7.92M 7.37M 7.18M 9.42M 8.05M 6.35M 5.84M 5.96M 5.47M 5.11M 5.69M 5.22M 4.99M 5.17M 5.29M
Research and Development Revenue Growth -87.73% +5.16% +10.70% +1.75% -9.08% -17.77% -21.18% +4.08% -15.41% -9.77% +14.31% -2.11% +19.22% +7.86% +18.24% +10.85% +11.74% -13.78% +10.66% -1.04% +23.61% +1.85% +5.28% +3.22% +6.70% -5.10% +7.42% +2.67% -23.78% +16.91% +26.89% +8.72% -2.10% +9.09% +6.94% -10.09% +9.01% +4.45% -3.40% -2.32% n/a